Gene Query: RTFDC1

Dataset Description Geneva Score
Genome-wide expression change by SHARPIN knockdown in MCF-7 cells 49.56
A Novel PI3K Regulator, ARID4B, Presents Synthetic Essentiality in PTEN-deficient Prostate Cancer 31.26
A Novel PI3K Regulator, ARID4B, Presents Synthetic Essentiality in PTEN-deficient Prostate Cancer [RNA-seq] 31.26
RNA Sequencing of default, melanocyte biased and enteric human neural crest populations (NC) and neuroectoderm (CNS) 25.63
Suppression of ribosomal pausing by eIF5A is necessary to maintain the fidelity of start codon selection (RNA-sequencing) 20.96
Suppression of ribosomal pausing by eIF5A is necessary to maintain the fidelity of start codon selection 20.96
A novel lncRNA lncRNA-AF339830 promotes colorectal carcinogenesis and glucose metabolism by stabilizing and specifying the transcription modification pattern of c-Myc 20.91
A novel lncRNA lncRNA-AF339830 promotes colorectal carcinogenesis and glucose metabolism by stabilizing and specifying the transcription modification pattern of c-Myc [RNA-Seq] 20.91
Detection of internal N7-methylguanosine (m7G) RNA modifications by mutational profiling sequencing 18.95
Transcriptome analysis of human immortilized astrocytes reprogrammed into dopaminergic neurons 18.77
MEF2C phosphorylation is required for chemotherapy resistance in acute myeloid leukemia 17.83
RNA-seq analyses of human prostate cancer cells 16.2
NET-CAGE Characterizes the Dynamics and Topology of Human Transcribed Cis-regulatory Elements 15.36
Transcriptomic insights into human decidual and peripheral blood CD8 T cells 15.17
Expression profile and potential functions of circulating long noncoding RNAs in acute ischemic stroke in the Southern Chinese Han population 14.99
Identification of transcription start sites for human A549 cell line using ReCappable-seq 14.9
ChIP-seq and RNA-Seq analyses of epithelial and mesenchymal cells - HMLE, N8, N8-CTx 14.65
RNA-Seq comparisons of gene expression profiles of epithelial and mesenchymal cells - HMLE, N8, N8-CTx 14.65
Activation of HOTTIP lncRNA perturbs HSC function leading to AML like disease 14.26
Selective expansion of myeloid and NK cells in humanized mice yields human-like vaccine responses (Experiment 1: RNA-seq) 14.25
BET bromodomain inhibitor iBET151 impedes human ILC2 activation and prevents experimental allergic lung inflammation 13.87
Proteinase-Activated Receptor 4 (PAR4) mediates cell membrane blebbing in a Gaq/11, Gai independent, RhoA and ß-arrestin-dependent manner. 13.63
Human blood CD1c⁺ dendritic cells encompass CD5-high and CD5-low subsets that differ significantly in phenotype, gene expression and functions 13.12
IMP3 regulated gene expression in breast cancer cells 12.83
Transcriptome-wide study of the response of human trabecular meshwork cells to the substrate stiffness increase 12.47
Transcriptome analysis of immature and matured human oocytes from patients of young and advanced maternal age 12.27
Sequencing Universal Human Reference RNA by Smart-seq and early barcoding library preparation methods 12.11
Gene expression comparison of resting human peripheral-blood NK cells and activated counterparts 11.78
Transcriptional profiling of microglia; current state of the art and future perspectives 11.71
Systematic Functional Dissection of Common Genetic Variation Affecting Red Blood Cell Traits 11.62
Systematic Functional Dissection of Common Genetic Variation Affecting Red Blood Cell Traits [mRNA-Seq] 11.62
Genome-wide analysis of herpes simplex virus type 1 (HSV-1) infected cells 11.44
Next Generation Sequencing Facilitates Quantitative Analysis of Wild Type and AXL-/- astrocytes Transcriptomes 11.42
Expression by CD133+ cells isolated from the adult human exocrine pancreas 10.93
Leukodystrophy-associated POLR3A mutations down-regulate the RNA polymerase III transcript and important regulatory RNA BC200 10.86
RNA-sequencing of human mammary epithelial cells (HMLEs) engineered to express either ER or ER-SOX4 with and without 4-OHT to induce nuclear translocation 10.78
Differential roles of human PUS10 in miRNA processing and tRNA pseudouridylation 10.77
RNA-dependent RNA polymerase sequence specificities of capsnatching viruses are tailored to aid viral replication 10.73
Quiescent glioblastoma cells shift to an epithelial-mesenchymal transition-like gene program 10.68
Enhancement of Arterial Specification in Human Pluripotent Stem Cell Cultures Promotes Definitive Hematoendothelial Program with Broad Myelolymphoid Potential 10.65
Tracing transcriptome profiles of human oocyte cultured by growth hormone or not in vitro by single cell RNA-seq 10.46
Ribosomal footprinting of MDA-Parental and MDA-LM2 10.41
Disrupted prenatal RNA processing and myogenesis in congenital myotonic dystrophy 10.12
Ribosomal footprinting of CN34-Parental and CN34-LM1a 10.11
Tracking distinct RNA populations using efficient and reversible covalent chemistry 10.09
Cohesin and CTCF Differentially Affect the Chromatin Architecture and Gene Expression in Human Cells 10.06
CROP-Seq in Primary Human T Cells 9.93
Exploring transcriptomic landscapes in red cell populations, in their extracellular vesicles and on single cell level 9.72
RNAseq of HEK293 cells after Chtop knockdown 9.57
Co-transcriptional loading of RNA export factors shapes the human transcriptome 9.57
Whole Transcriptome RNASeq Data for Cell-Sorted Antibody Secreting Cells (ASC) 9.54
Effects of Cardiac Glycosides on RNA Expression in Prostate Cancer LNCaP-abl Cells 9.51
MicroRNA-mediated suppression of the TGF-β pathway confers transmissible and reversible CDK4/6 inhibitor resistance (RNA-Seq) 9.4
MicroRNA-mediated suppression of the TGF-β pathway confers transmissible and reversible CDK4/6 inhibitor resistance 9.4
Comparing oestrogen-responsive genes in endometrial and breast cancer cell lines 9.34
Global analysis of pre-mRNA subcellular localization upon splicing inhibition by spliceostatin A 9.28
FOXA1 upregulation promotes enhancer and transcriptional reprogramming in endocrine-resistant breast cancer 9.06
FOXA1 upregulation promotes enhancer and transcriptional reprogramming in endocrine-resistant breast cancer [RNA-seq] 9.06
RNA-seq analysis of A2780 and OVCAR3 human ovarian cancer cell lines after overexpression of collagen type XI alpha 1 (COL11A1) 8.86
EGR1-controlled transcriptome of T HESCs 8.8
RNA-seq profiling of the human neutrophil genome during PMA- and E. coli encounter-induced activation 8.76
Human neutrophil genome during PMA- and E. coli encounter-induced activation 8.76
Comparative transcriptomic analysis of human and Drosophila extracellular vesicles reveals extensive conservation 8.73
Evolving Spindlin1 Small Molecule Inhibitors Using Protein Microarrays 8.71
Hit-and-run' programing of CAR-T cells using mRNA nanocarriers 8.59
Generation of targeted homozygosity in the genome of human induced pluripotent stem cells 8.58
Genome-wide analysis of YAP and TFCP2 down-regulated genes in liver cancer cells 8.46
Genome-wide analysis of YAP and TFCP2 occupancy and regulated expression in liver cancer cells 8.46
Human embryonic stem cell, chimpanzee induced pluripotent stem cell, orangutan induced pluripotent stem cell, rhesus embryonic stem cell, and their derived cortical organoid RNA-seq 8.43
A Surveillance System of Active Enhancers by a RACK7-histone Demethylase Complex 8.38
Global Transcriptional analysis of human spinal cord and neocortical neuroepithelial stem (NES) cells 8.35
PTBP1 excludes UPF1 to protect long 3'UTRs from nonsense-mediated mRNA decay 8.33
Single-cell RNA-seq reveals differentiation of bona fide human pDCs and cDC1s in cultures of cord blood CD34+ progenitors, and a newly identified terminal differentiation step of cDC1s 8.31
RIG-I and MDA5 fRIP during KSHV lytic reactivation 8.31
Effects of Freeze-Thawing and Intravenous Infusion on Mesenchymal Stromal Cell Gene Expression 8.3
Rational targeting of RNA structure in SMN2 transcripts reverses Spinal Muscular Atrophy molecular phenotypes 8.25
mRNA expression profile of Lymphocytes 8.22
RNA-seq of YB5 cells treated with Proscillaridin A 8.17
Oncogenic Notch promotes long-range regulatory interactions within hyperconnected 3D cliques [HCC1599_RNA-seq] 8.0
Arginine citrullination at the C-terminal domain controls RNA Polymerase II transcription 7.99
T47D RNA-seq and ChrRNA-seq data 7.99
H3B-8800, a novel oral splicing modulator, induces lethality in spliceosome mutant cancers [Nalm-6] 7.95
Gene expression changes upon drug withdrawal (A375/451Lu cell lines) 7.94
Study functions of ADAR proteins using next generation sequencing of genome and transcriptome 7.91
NRDE2 negatively regulates nuclear exosome functions 7.9
Widespread N6-methyladenosine-dependent RNA Structural Switches Regulate RNA-Protein Interactions 7.83
Gene expression profiling of neural crest progenitor cultures derived from human embryonic stem cells carrying nonsense mutations in the Polycomb gene ASXL1 [HET] 7.81
Circular RNAs are down-regulated in KRAS mutant colon cancer cells and can be transferred to exosomes 7.8
mRNA expression profiling in MDA-MB-231 (LM1) cells with a tet-incible MBD2 or p66α knock down, or treated with MBD2-targeting small molecule ABA or APC 7.7
EIF1AX-A113 splice and RAS mutations cooperate to drive thyroid tumorigenesis through ATF4 and c-MYC 7.65
Translocation of dense granule effectors across the parasitophorous vacuole membrane in Toxoplasma-infected cells requires the activity of ROP17, a rhoptry protein kinase 7.64
Trans-differentiation of human adult peripheral blood T cells into neurons 7.62
Transcriptional profile of human STAT1-/- fibroblasts expressing IFI6 or empty control vector 7.61
The SPOP-containing Complex Functions as an E3 Ligase for SETD2 to Regulate Gene-Specific H3K36me3-Coupled Alternative Splicing 7.51
ARID1A loss impairs enhancer-mediated gene regulation and drives colon cancer in mice [HCT116_RNA-seq] 7.45
ARID1A loss impairs enhancer-mediated gene regulation and drives colon cancer in mice 7.45
Ribosomal footprinting of MDA_Ctrl and MDA_Arg overexpression cell lines 7.44
HMGA2 Promotes Long-Term Engraftment and Myelo-Erythroid Differentiation of Human Hematopoietic Stem and Progenitor Cells 7.44
Error-free and error-prone DNA repair gene expression through reprogramming and passage in human iPS cells 7.44
Platelet Transcriptome Profiling in HIV and ABCC4 as a Biomarker of Platelet Activity 7.42
Biochemical fractionation of HEK293 nuclei and RNA-seq of chromatin-associated and soluble-nuclear RNA 7.39
Knockout human reveal an essential role for Paternally Expressed 10 (PEG10) in JEG3 cell line development 7.37
MOF acetyl transferase regulates transcription and respiration in mitochondria 7.3
A Surveillance System of Active Enhancers by a RACK7-histone Demethylase Complex (RNA-Seq I) 7.28
Identification of mRNAs with reduced ribosomal loading upon knock-down of translation factor DAP5 from hESCs. 7.25
β-catenin/Tcf7l2 dependent transcriptional regulation of GLUT1 gene expression by Zic family proteins in colon cancer 7.18
Effect of CHKA knockdown on C4-2 cell transcriptome 7.12
Co-expression of CD163 and CD141 Identifies Human Circulating IL-10-Producing Dendritic Cells (DC-10) 7.11
Co-expression of CD163 and CD141 Identifies Human Circulating IL-10-Producing Dendritic Cells (DC-10) [RNA-seq] 7.11
K562 polyA RNA-Seq 7.03
High RNA polymerase II occupancy on herpes simplex virus 1 late genes early in infection suggests progression to elongation is a critical switch to trigger late viral gene expression 6.93
KMT2D regulates p63 target enhancers to coordinate epithelial homeostasis [RNA-Seq] 6.92
KMT2D regulates p63 target enhancers to coordinate epithelial homeostasis 6.92
Human Cactin interacts with DHX8 and SRRM2 to assure efficient pre-mRNA splicing and sister chromatid cohesion. 6.92
Measuring the effect of MYC on transcription during the DNA double-strand break response by RNA-seq of newly synthesized transcripts 6.88
Global transcriptional changes in the JJN3 myeloma cell line that occur as a result of treatment with 2 pyrrolobenzodiazepine (PBD) monomers 6.87
Integrating single-cell transcriptomic data across different conditions, technologies, and species 6.87
IFN-g Regulates mTORC1, Cellular Metabolism and mRNA Translation to Potentiate Inflammatory Macrophage Activation 6.85
IFN-g Regulates mTORC1, Cellular Metabolism and mRNA Translation to Potentiate Inflammatory Macrophage Activation [RNA-Seq] 6.85
Transcriptomics of human macrophages upon infection with Legionella pneumophila and two isogenic mutants, LamA and AnkH using RNA-seq 6.84
Human CD4+CD103+ cutaneous resident memory T cells are found in the circulation of healthy subjects 6.8
Histone H3 Lysine4 Acetylation-Methylation Dynamics Define Breast Cancer Subtypes 6.77
Histone H3 lysine 4 acetylation-methylation dynamics define breast cancer subtypes [RNA-seq] 6.77
AKT Inhibition Promotes Non-autonomous Cancer Cell Survival [RNA-Seq] 6.76
AKT Inhibition Promotes Non-autonomous Cancer Cell Survival 6.76
Transcriptome profile of ATP7B KO cells and WT cells treated with Copper (Cu) to study Autophagy as a pro-survival mechanism in Wilson disease 6.75
miR-191 regulates human cell proliferation and directly targets multiple oncogenes [seq] 6.71
Genome wide miR-191 target profile determined by RIP and gene expression profiling 6.71
Stem and effector CD8 T-cells from human cancers 6.69
3’ Uridylation Expands miRNA Target Repertoire 6.66
mRNA gene expression profiling in a human AML cell line treated with small molecule inhibitors that impact different RNA polymerase transcription complexes, or their combination, in comparison to a global DNA-damaging anthracycline compound 6.65
Global analysis of enhancer targets: Mosaic-seq 6.55
Dynamics of the human and viral m6A RNA methylomes during HIV-1 infection of T cells 6.49
RNA sequencing of CACO-2 cells incubated with bifidobacteria grown on human milk oligosaccharides. 6.48
Human serum and heparin-free platelet lysate as appropriate xeno-free alternatives for production of human MuStem cell batches 6.43
The effect of Abl kinases on non-small cell carcinoma global transcriptome 6.38
RNA G-quadruplexes cause eIF4A-dependent oncogene translation in cancer 6.35
HITS-CLIP analysis uncovers a link between the Kaposi's sarcoma associated herpesvirus ORF57 protein and host pre-mRNA metabolism 6.33
Human Treg NaCl stimulation 6.32
Non-synchronized cell cycle transcriptomics in U2OS and HeLa cancer cells 6.23
Single-cell Map of Diverse Immune Phenotypes in the Breast Tumor Microenvironment - 5' RNA sequencing and TCR sequencing 6.23
Transcriptome analysis reveals malignant and hypoxic signature of glioblastoma 6.21
miRNA-1343 attenuates pathways of fibrosis by targeting the TGF-beta receptors [RNA-seq] 6.19
Heterogeneous nuclear ribonucleoprotein C1/C2 links transcriptional and splicing actions of 1,25-dihydroxyvitamin D 6.16
Expression analysis of Mebendazole treated THP-1 cells in three paired samples 6.15
Monitoring Nivolumab binding as a method to clarify the residual therapeutic effects and to characterize the immune profile in antibody bound T cells in previously treated non-small cell lung cancer patients 6.12
Distinct gene expression profile of Huh7 cell lines stably overexpressing CRABP1 or 2 6.12
A NIK-SIX signaling axis controls inflammation by targeted silencing of noncanonical NF-κB 6.1
Expression analysis of THP1 cells following shRNA knock-down of RUVBL2 6.04
Global hypomethylation mediated changes regulate constitutive PD-L1 expression in melanoma 6.04
Global hypomethylation mediated changes regulate constitutive PD-L1 expression in melanoma [RNA-Seq] 6.04
MiR-CLIP capture of a miRNA targetome uncovers a lincRNA H19-miR-106a interaction [III] 6.0
Potent antitumor activity of Cabozantinib, a c-MET and VEGFR2 Inhibitor, in a Colorectal Cancer Patient-derived Tumor Explant Model 6.0
High level DNA repair gene expression in human ES cells 5.99
Neurofibroma 5.97
Differential expression in wild-type and mutant neurofibroma and MPNST cell lines 5.97
Super-enhancer-driven CCAT1 is co-activated by SOX2 and TP63 and promotes squamous cancer from esophagus, head and neck and lung [RNA-seq] 5.95
Super-enhancer-driven CCAT1 is co-activated by SOX2 and TP63 and promotes squamous cancer from esophagus, head and neck and lung 5.95
Ribosome profiling of A549 cells depleted of RPLP1 and RPLP2 and infected with DENV. 5.95
Extensive remodeling of DC function by rapid maturation-induced epigenetic gene silencing 5.95
Extensive remodeling of DC function by rapid maturation-induced epigenetic gene silencing [RNA-Seq] 5.95
The hematopoietic master transcription factor PU.1 requires its interaction with the SWI/SNF remodeler to access chromatin de novo [RNA-seq] 5.94
The hematopoietic master transcription factor PU.1 requires its interaction with the SWI/SNF remodeler to access chromatin de novo 5.94
Direct identification of endogenous SMG6 targets and a preferred motif spanning SMG6 cleavage sites by parallel analysis of RNA ends in human cells 5.91
Discovery of cis-spliced chimeric RNAs between adjacent genes in human prostate cells 5.9
Nm-seq finds thousands of modified 2’-O-methylation sites in mRNA with base precision 5.9
Transcriptome analysis of human embryonic stem cells (hESCs) and human fibroblasts upon rapamycin 5.89
Genome-wide CRISPR-Cas9 screen identifies SLC1A3 as a key contributor to L-asparaginase Resistance in Solid tumors 5.88
RNAseq of ribosomal fractionation to assess the effect of CBFB on translation regulation 5.87
G-quadruplex structures mark human regulatory chromatin 5.86
hnRNP C is a key regulator of protein synthesis in mitosis 5.84
scRNASeq analysis of cycling cardiomyocytes 5.83
Toxoplasma gondii remodels the cis-regulatory landscape of infected human host cells 5.82
Toxoplasma gondii remodels the cis-regulatory landscape of infected human host cells [RNA-seq] 5.82
The LINC01138 Drives Malignancies via Activating Arginine Methyltransferase 5 in Hepatocellular Carcinoma 5.82
BET-Bromodomain Inhibitors Engage The Host Immune System And Regulate Expression Of The Immune Checkpoint Ligand PD-L1 [3mRNA-seq] 5.8
BET-Bromodomain Inhibitors Engage The Host Immune System And Regulate Expression Of The Immune Checkpoint Ligand PD-L1 5.8
Mitochondrial dsRNA triggers antiviral signalling in humans 5.8
Genes directly regulated by NF-κB in human hepatocellular carcinoma HepG2 5.76
Genes directly regulated by NF-κB in human hepatocellular carcinoma HepG2 [RNA-seq] 5.76
RNA-Seq to assess the transcriptional effects of G quadruplex stabilization by the G4 ligand PhenDC3 in HT-1080 cells 5.75
RNA-seq and ChIP-seq analysis of BMI1 or RING1B-silenced prostate cancer cells C4-2 5.68
RNA-seq analysis of melanoma and carcinoma cells expressing FOXQ1 5.67
Knockdown of ADNP in HCT116 colon cancer cells 5.66
Gene-Centric Functional Dissection of Human Genetic Variation Uncovers Regulators of Hematopoiesis 5.65
Patient-derived xenograft platform for metastatic melanoma 5.65
Utilizing single-cell variations to reveal environment-dependent tuning of network connectivity in human macrophages 5.64
Utilizing single-cell variations to reveal environment-dependent tuning of network connectivity in human macrophages (RNA-Seq, CAGE and ChIP-Seq) 5.64
Small-molecule targeting of brachyury transcription factor addiction in chordoma [rnaseq_sgrna] 5.62
Diverse AR-V7 cistromes in castration-resistant prostate cancer are governed by HoxB13 5.59
Poly(ADP-ribosyl)ation dependent changes in CTCF-chromatin binding and gene expression in breast cells 5.53
Human Nonsense-Mediated RNA Decay Initiates Widely by Endonucleolysis and Targets snoRNA Host Genes 5.53
Loss of CHD1 facilitates oncogenic hijacking of AR during cancer progression [RNA-seq] 5.51
Loss of CHD1 facilitates oncogenic hijacking of AR during cancer progression 5.51
RNA editing in nascent RNA affects pre-mRNA splicing 5.51
Biosynthesis of histone messenger RNA employs a specific 3' end endonuclease 5.51
miR-126 Orchestrates an Oncogenic Program in B-Cell Precursor Acute Lymphoblastic Leukemia 5.5
The age and genomic integrity of neurons after cortical stroke in humans 5.5
Activation of PARP-1 by snoRNAs Controls Ribosome Biogenesis and Cell Growth via the RNA Helicase DDX21 (RNA-Seq) 5.49
Activation of PARP-1 by snoRNAs Controls Ribosome Biogenesis and Cell Growth via the RNA Helicase DDX21 5.49
IgG immunocomplexes sensitize human monocytes for inflammatory hyperactivity via transcriptomic and epigenetic reprogramming in Rheumatoid Arthritis 5.47
The bromodomain protein BRD4 regulates splicing during heat shock 5.44
Characterization of transcriptomics landscape in HUVEC cells exposed to oxidative stress 5.38
Time-course expression data from HEK293∆RAF1:ER cells stimulated with 4OHT and labelled with 4SU 5.37
Time-course expression data from HEK293∆RAF1:ER cells stimulated with 4OHT, U0126, CYHX, ActD, EGF, FGF, or IGF and labelled with 4SU 5.37
XBP1s Activation Globally Remodels N-Glycan Structure Distribution Patterns 5.35
N6-methyladenosine mRNA marking promotes selective translation of regulons required for human erythropoiesis[Ribosome Profiling] 5.29
Systematic discovery of endogenous human ribonucleoprotein complexes 5.28
Epigenome-wide Effects of Vitamin-D on Bronchial Epithelial Cells using ATAC-Seq and RNA-seq 5.26
Chemical Modulation of Glycolysis Regulates the KEAP1-NRF2 Pathway Through a Metabolite-Induced Posttranslational Modification 5.23
Identification of renal resident macrophages across species 5.21
RNA sequencing of HepG2 cells treated with estradiol or estrogen receptor agonist 5.2
Effect of CRISPR-Cas9 mediated knock-out of integrin alpha2 on the transcriptome of DU145 prostate cancer cell grown as a spheroid culture 5.16
RNAseq to determine gene expression changes following depletion of SETDB1 in THP-1 AML Cells 5.11
Assessing the effect of SUPT4H1 RNAi on the transcription of a repeat-containing reporter construct 5.11
The long non-coding RNA MALAT1 contributes to the pathogenesis of multiple sclerosis through alternative splicing and backsplicing regulation 5.1
RNASeq of MV4;11 cells transduced with scramble shRNA or BRD4 shRNA in combination with DMSO or SGC0946 5.07
RNA seq comparison between scrambled and shGRP78 cells 5.05
Human cells contain natural double-stranded RNAs with potential regulatory capacity 5.04
Characterization of human CDK12 and CDK13 in the regulation of RNA processing 5.01
An aspartyl protease defines a novel pathway for export of Toxoplasma proteins into the host cell 4.88
The CDK7 Inhibitor THZ1 Alters RNA Polymerase Dynamics at the 5’ and 3’ Ends of Genes 4.86
Next Generation Sequencing Analysis of Colorectal Cancer Tissue Transcriptomes 4.84
RNA-seq of RKO cells with cTAZ KO or putback 4.84
Co-regulation of splicing by Rbfox1 and hnRNP M [hnRNPM k-d+Rbfox1 RNA-Seq] 4.8
Co-regulation of splicing by Rbfox1 and hnRNP M 4.8
Isolation and Functional Interrogation of Adult Human Prostate Epithelial Stem Cells at Single Cell Resolution 4.79
CXCR4 regulates extra-medullary myeloma through epithelial-mesenchymal transition-like transcriptional activation 4.78
Epigenetic siRNA and chemical screens identify SETD8 inhibition as a new therapeutic strategy of p53 reactivation in high-risk Neuroblastoma. 4.77
Differetially expressed genes after hTR overexpression in U2OS cells 4.76
Profile of gene expression in U87-MG xenografts expressing control vector (V0), the ubiquitin ligase KPC1 or the p50 subunit of the NF-kB transcription factor, using RNASeq analysis of transcripts mapped independently to the human and murine genomes 4.75
X-Ray induced DNA-Hydroxymethylation changes 4.69
pSILAC mass spectrometry reveals ZFP91 as novel IMiD dependent substrate of the CRL4CRBN ligase 4.66
IGF2BP1 promotes SRF-dependent transcription in cancer in a m6A- and miRNA-dependent manner [Huh-7] 4.65
IGF2BP1 promotes SRF-dependent transcription in cancer in a m6A- and miRNA-dependent manner 4.65
Transcriptomic analysis of the HOTAIR-regulated genes 4.58
Prediction of bacterial infection outcome using single cell RNA-seq analysis of human immune cells [sorted population Bulk RNA-seq] 4.55
RNA-Seq analysis and comparison of corneal epithelium in keratoconus and myopia patients 4.5
Newly defined ABCB5+ dermal mesenchymal stem cells promote healing of chronic iron overload wounds via secretion of interleukin-1 receptor antagonist 4.48
Identification of transcripts altered upon LIN-41 knockdown in human embryonic stem cells 4.46
Profiling of protrusion-enriched RNAs from human breast cancer cell line MDA-MB-231 4.46
The Developmental Heterogeneity of Human Natural Killer Cells Defined by Single-cell Transcriptome 4.44
Nascent RNA Sequencing after NMYC activation in SH-EP MYCNER cells 4.42
Anti-inflammatory effect of indoleacrylic acid (IA) 4.41
Innate Immune Landscape in Early Lung Adenocarcinoma by Paired Single-Cell Analyses 4.4
DDX54 regulates transcriptome dynamics during DNA damage response [4SU-seq] 4.37
RNA sequencing of primary human platelets and in vitro cell lines 4.37
Identification and characterization of circular RNAs as a new class of putative biomarkers in human blood 4.34
mRNA expression profile of Lymphocytes by high-throuput sequencing 4.27
Transcriptome sequencing after MAGOHB knockdown in MAGOH-deleted or non-deleted cancer cells 4.25
Sirt6 Oncogene Mediates PI3K/Akt Signaling Activation in Diffuse Large B-Cell Lymphoma 4.24
Regulation of DNA methylation landscape in human somatic cell reprogramming by miR-29 family (RNA-seq) 4.21
Regulation of DNA methylation landscape in human somatic cell reprogramming by miR-29 family 4.21
Reversible LSD1 Inhibition with HCI-2509 induces the p53 gene expression signature in high-risk neuroblastoma cells 4.18
RNA-seq of cultured human kidney peritubular microvascular endothelial cells following exposure to cyclosporine A 4.16
RNA-Seq analysis of JIB-04 effects on global cellular transcription and HIV in 2D10 T cells 4.15
Comparative analysis of kidney organoid and adult human kidney single cell and single nucleus transcriptomes 4.11
Profiling of lung tumor-infiltrating CD8 T cells according to their expression status of CD39 4.07
DNMT and HDAC inhibitors globally induce cryptic TSSs encoded in long terminal repeats 4.04
Gene expression profiles of 4-1BB+PD-1-high, 4-1BB-PD-1-high, and PD-1-int tumor-infiltrating CD8 T cells in hepatocellular carcinoma 4.03
Unraveling cis-regulatory elements by mapping structural changes in mRNAs 4.02
mRNA Sequencing of Human PromoCells Using 3'-directed Digital Gene Expression (3'-DGE) Technique 3.97
Vitamin C Promotes Apoptosis in Breast Cancer Cells by Increasing TRAIL Expression 3.97
Regulation of mRNA half-life by an inhibitor of human decapping enzyme Dcp2 following transcription shutoff in HEK293T cells 3.95
TUT-DIS3L2 is a mammalian surveillance pathway for aberrant structured non-coding RNAs. 3.9
Uridylation-mediated RNA quality control pathway in mammalian cytoplasm [RNA-Seq] 3.9
Gene expression changes in HSV-1 infected HeLa cells with knockdown of B2M 3.89
Membrane Metallo-Endopeptidase (Neprilysin) Regulates Inflammatory Response and Insulin Signaling in White Preadipocytes (RNA-Seq) 3.89
Membrane Metallo-Endopeptidase (Neprilysin) Regulates Inflammatory Response and Insulin Signaling in White Preadipocytes 3.89
NOTCH1 activation in breast cancer confers sensitivity to inhibition of SUMOylation 3.88
Expression profile of wild type (WT) vs miR-155-/- in FLT3-ITD+ AML (MV4-11) cell lines 3.87
Genome-wide CRISPR-Cas9 screen identifies functionally relevant microRNAs in AML 3.87
Cell cycle dynamics of human pluripotent stem cells primed for differentiation 3.86
RNA sequencing of human mammary epithelial cells 3.84
Structural basis for human respiratory syncytial virus NS1-mediated modulation of host responses 3.79
Gene expression in skeletal muscle in older individuals subject to ten days of complete bed rest. 3.79
CDK12 regulates alternative last exon mRNA splicing and promotes invasion of a breast cancer cell line 3.76
RNA sequencing to study transcriptomic changes in DLD-1 (colorectal adenocarcinoma) cells exposed to soft polyacrylamide matrices (~2 kPa and ~55 kPa) for short time scale of 90 minutes 3.76
RNA-sequencing study of peripheral blood monocytes for chronic periodontitis 3.76
MRTF activates TEAD-YAP target gene expression 3.75
The ZZ-type zinc finger of ZZZ3 modulates the ATAC complex-mediated histone acetylation and gene activation 3.75
Combined Genome and Transcriptome Sequencing to Identify Allelic Selection in Epithelial Ovarian Cancer 3.73
Pseudotime Ordering of Single Human Beta-Cells Reveals States of Insulin Production and Unfolded Protein Response 3.7
Identification of a unique subtype of lung squamous cell carcinoma defined by SOX2 and a neural differentiation factor BRN2 [RNA-seq] 3.68
Identification of a unique subtype of lung squamous cell carcinoma defined by SOX2 and a neural differentiation factor BRN2 3.68
Single-cell epigenomics maps the continuous regulatory landscape of human hematopoietic differentiation 3.67
Single-cell epigenomics maps the continuous regulatory landscape of human hematopoietic differentiation [bulk RNA-Seq] 3.67
MEF2C phosphorylation is required for chemotherapy resistance in acute myeloid leukemia [mutant MEF2C] 3.65
RNA sequencing Facilitates Quantitative Analysis of luminal breast cancer cells and basal breast cancer cells Transcriptomes 3.65
RNA-Sequencing approach for the identification of novel long non-coding RNA biomarkers in colorectal cancer 3.63
A novel Menin-MLL inhibitor induces specific chromatin changes and eradicates disease in models of MLL-rearranged leukemia [RNA-Seq II] 3.6
Contribution of synergism between PHF8 and HER2 signalling to breast cancer development and drug resistance  3.58
Transcriptomic responses to Ivacaftor and prediction of Ivacaftor clinical responsiveness 3.58
Positively selected enhancer elements endow tumor cells with metastatic competence 3.57
IL-21/type I interferon interplay regulates neutrophil-dependent innate immune responses to Staphylococcus aureus 3.55
Gene expression in control and DOCK8 CRISPR KHYG1 NK cells 3.54
Transcriptome wide analysis of translation efficiency in MCF7 cells using polysome profiling with and without eIF4A inhibition by hippuristanol treatment 3.54
Rnase L reprograms translation by widespread mRNA turnover escaped by antiviral mRNAs 3.52
Acetylation of spliceosome protein PHF5A modulates stress responses and colorectal carcinogenesis through alternative splicing mediated upregulation of KDM3A 3.51
Ribosome profiling upon inhibition of eIF4A 3.5
Identification of renal resident macrophages across species [C1] 3.48
Next Generation Sequencing Facilitates Quantitative Analysis of SW480 cells and HPSE-knockdown SW480 cells Transcriptomes 3.48
CT Irradiation Induced Changes of Gene Expression within Peripheral Blood Cells 3.38
Toxoplasma gondii infection of human retinal pigment epithelial cells 3.36
RNA-sequencing of highly pure synovial tissue macrophages reveals two distinct osteoarthritis subgroups that indicate different disease mechanisms. 3.3
The RNA helicase DDX39B regulates IL7R alternative splicing reducing the risk of Multiple Sclerosis 3.3
Enhancer Sequence Variants and Transcription Factor Deregulation Synergize to Construct Pathogenic Regulatory Circuits in B Cell Lymphoma 3.29
Enhancer Sequence Variants and Transcription Factor Deregulation Synergize to Construct Pathogenic Regulatory Circuits in B Cell Lymphoma (RNA-Seq) 3.29
Transcriptomic profiling of cleavage-resistant RIPK1 induced autoinflammation syndrome patients 3.28
Identification of atheroprone shear stress responsive regulatory elements in endothelial cells 3.27
SNHG15 is a bifunctional MYC-regulated noncoding locus encoding a lncRNA that promotes cell proliferation, invasion and drug resistance in colorectal cancer by interacting with AIF 3.26
Transcriptome landscape of HeLa response upon triamcinolone acetonide 3.25
RNA-seq reveals abundant circRNA, lncRNA and mRNA in blood exosomes of patients with colorectal carcinoma 3.19
Coordinate regulation of alternative pre-mRNA splicing events by the human RNA chaperone proteins hnRNPA1 and DDX5 3.16
NAPRT activation of macrophages 3.11
mRNA expression in human DAOY cells 3.06
TimeLapse-seq: adding a temporal dimension to RNA sequencing through nucleoside recoding 3.04
Expression data for KDM1B knockdown in Glioma-Initiating Cells (GICs) 3.04
MiR-CLIP capture of a miRNA targetome uncovers a lincRNA H19-miR-106a interaction 3.02
Transcriptomic analysis of acute mitochondrial pyruvate carrier inhibition using UK5099 in ABL prostate cancer cells 3.01
Engineered Nanointerfaces for Microfluidic Isolation and Molecular Profiling of Tumor-specific Extracellular Vesicles 2.97
CBFβ-MYH11 fusion blocks hematopoietic differentiation via repression of a GATA2 gene program 2.95
Topoisomerase 1 inhibition suppresses inflammatory genes and protects from death by inflammation (RNA-Seq) 2.9
Topoisomerase 1 inhibition suppresses inflammatory genes and protects from death by inflammation 2.9
Mutually Exclusive CBC-Containing Complexes Contribute to RNA Fate. 2.87
RNA:DNA hybrids in the human genome have distinctive nucleotide characteristics, chromatin composition, and transcriptional relationships (RNA-seq) 2.87
RNA:DNA hybrids in the human genome have distinctive nucleotide characteristics, chromatin composition, and transcriptional relationships 2.87
Derivation of kidney organoids from human pluripotent stem cells [RNA-Seq: Data Set 2] 2.84
Does osteogenic potential of clonal human bone marrow mesenchymal stem/stromal cells correlate with their vascular supportive ability? 2.83
Transcriptome analysis of peripheral blood monocytes 2.81
Genome-wide Dose-dependent Inhibition of Histone Deacetylases Reveals Their Roles in Enhancer Remodeling and Suppression of Oncogenic Super-enhancers 2.77
Activity-dependent transcriptional changes in human neurons 2.76
A Non-Canonical Nuclear Activity Triggered by Small RNAs and Argonaute Proteins in Human Cells 2.75
NF-κB p65 dimerization and DNA-binding is important for inflammatory gene expression 2.71
Chemotherapeutic drugs inhibiting Topoisomerase 1 activity inhibit TNF-induced inflammatory gene expression 2.7
Clonally expanded CD8 T cells patrol Alzheimer's cerebrospinal fluid 2.65
Clonally expanded CD8 T cells patrol Alzheimer's cerebrospinal fluid [TEMRA] 2.65
RNA-Seq data of NCI-H82 cells expressing a Dox-On pRB (pTripZ RB1) grown in the presence or absence of DOX and then treated with vehicle or AZD2811. 2.62
Comprehensive Epigenetic Landscape of Rheumatoid Arthritis Fibroblast-like Synoviocytes [RNA-seq] 2.61
Comprehensive Epigenetic Landscape of Rheumatoid Arthritis Fibroblast-like Synoviocytes 2.61
Global host gene expression changes in KSHV+ PEL cells upon KSHV reactivation 2.6
RNA-Seq analysis of 4N and 2N RPE1 cells following polyploid induction via cytokinesis failure by siRNA knockdown of Anillin [tpo8] 2.55
Non-coding and coding transcriptional profiles are significantly altered in pediatric Retinoblastoma tumors 2.54
Whole transcriptome sequencing identifies increased CXCR2 expression in PNH granulocytes 2.47
Solid phase chemistry to covalently and reversibly capture thiolated RNA 2.44
Epigenetic activation and memory at a TGFB2 enhancer in systemic sclerosis 2.42
UMI-count modeling and differential expression analysis for single-cell RNA sequencing 2.37
Circular RNA profiling reveals the different distribution/characteristic and possible transport mechanism among the subcellular fractions 2.36
Trisomy of a ‘Down syndrome critical region’ globally amplifies transcription via HMGN1 overexpression [NALM6 RNA-Seq] 2.32
An optimization system for isolating and sequencing of single human colon cancer cells 2.32
RNA-sequencing of the brain transcriptome implicates dysregulation of neuroplasticity, circadian rhythms, and GTPase binding in bipolar disorder 2.29
Expression profiling of ILC transitional populations and Aiolos accessability and H3K27ac histone modifications in transfected MNK3 cells 2.22
RNA-Seq from human ILC transitional populations 2.22
Molecular Pathology of adverse local tissue reaction caused by metal-on-metal implants 2.09
Differential responses of human fetal brain neural stem cells to Zika virus infection 2.07
Identification of the RB loss-induced transcriptome and E2F1 cistrome in prostate cancer 2.03
Identification of the RB loss-induced transcriptome in prostate cancer [RNA] 2.03
An siRNA screen identifies CHD4 as a target for epigenetic therapy 1.98
GATA3 enhances the neurogenic potential of primary human astrocytes after traumatic injury [exp2] 1.98
RNA-seq of HEK293T cells overexpressing TET1-FL or TET1-ALT 1.98
A stably self-renewing adult blood-derived induced neural stem cell exhibiting patternability and epigenetic rejuvenation 1.95
Gene expression profile of calcified and normal tricuspid aortic valves by RNA sequencing. 1.94
Complement protein C1q modulates macrophage molecular signaling and inflammatory responses during ingestion of atherogenic lipoproteins 1.93
Tracing Enhancer Networks using Epigenetic Traits (TENET) 1.92
Cap-specific terminal N6-methylation of RNA by an RNA polymerase II-associated methyltransferase. 1.89
RNA Expression Profile of Calcified Bicuspid, Tricuspid and Normal Human Aortic Valves by RNA Sequencing [TAV] 1.86
RNA sequencing analysis of selumetinib-resistant CRC cells lines 1.85
Ebola virus (EBOV) infection of ARPE-19 cells 1.81
A monocyte gene expression signature in the early clinical course of Parkinson’s disease 1.8
mitoCPR - a surveillance pathway that protects mitochondria in response to mitochondrial import stress [human] 1.77
mitoCPR - a surveillance pathway that protects mitochondria in response to mitochondrial import stress 1.77
Aging-associated patterns in the expression of human endogenous retroviruses 1.72
The cohesin complex prevents Myc-induced replication stress 1.71
Transcriptional profiling of SF295 cells following MTF1 knockout by CRISPR/Cas9 1.71
Single-cell transcriptomic analysis of tissue resident memory T cells in human lung cancer [ 10x genomics] 1.7
Simultaneous profiling of sexually transmitted bacterial pathogens, microbiome, and concordant host response in cervical samples using whole transcriptome sequencing analysis 1.68
PRMT5 Interacts with the BCL6 Oncoprotein and is Required for Germinal Center Formation and Lymphoma Cell Survival 1.67
Tunable protein synthesis by transcript isoforms in human cells (Transcript Isoforms in Polysomes sequencing: TrIP-seq) 1.56
B-cell activating factor (BAFF) stimulation of Burkitt Lymphoma cell line 1.53
B-cell activating factor (BAFF) stimulation of Burkitt Lymphoma cell line [RNA-Seq] 1.53
JQ1 +/- Vemurafenib in BRAF mutant melanoma (A375) 1.5
Precise Gene Editing Preserves Hematopoietic Stem Cell Function Following Transient p53-Mediate DNA Damage Response [bulk RNA-seq] 1.49
Differential gene expression profiles in imatinib-resistant cell lines 1.48
N6-methyladenosine Recruits HNRNPG for Alternative Splicing Regulation 1.48
RNASeq of mouse, human, and non-human primate primary dermal fibroblasts to poly(I:C) transfection 1.47
CDK4/6 inhibitors target SMARCA4-determined cyclin D1 deficiency in hypercalcemic small cell carcinoma of the ovary (I) 1.44
A non-canonical role of YAP/TEAD is required for activation of estrogen-regulated enhancers in breast cancer 1.33
A non-canonical role of YAP/TEAD is required for activation of estrogen-regulated enhancers in breast cancer [RNA-seq] 1.33
Interactome (iCLIP) and Translatome ( Polysome profiling) of Musashi 2 (MSI2) targets in K562 1.3
Suppression of the FOXM1 transcriptional program via novel small molecule inhibition 1.3
Epigenomes and transcriptomes of human monocytes before and after in vivo exposure to Bacillus Calmette-Guérin vaccine 1.29
MicroRNAs reinforce repression of PRC2 transcriptional targets independently and through a feed-forward regulatory network with PRC2 [RNA-seq] 1.28
MicroRNAs reinforce repression of PRC2 transcriptional targets independently and through a feed-forward regulatory network 1.28
RNA-Seq of polysome profiling fractions and whole cell lysates of UVB-irradiated N-TERT keratinocytes 1.26
Similarity of therapeutic networks induced by a multi-component herbal remedy in neurovascular unit cells 1.25
Genomic deletion of malic enzyme 2 confers collateral lethality in pancreas cancer 1.21
Metabolism as an early predictor of DPSCs aging 1.16
Effects of Inhibition of CDK8/19 Mediator Kinase by Senexin B in HEK293 cells treated with or without TNF-alpha 1.15
Polysome profiling RNAseq of cells transfected with an oligonucleotide targeting the ES6S region of the 40S subunit 1.12
The Regulation of IFN Type I Pathway Related Genes RSAD2 and ETV7 Specifically Indicate Antibody-Mediated Rejection After Kidney Transplantation 1.1
Arrayed molecular barcoding identifies TNFSF13 as a positive regulator of acute myeloid leukemia-initiating cells 1.08
Treatment of prostate cancer cells with S-adenosylmethionine leads to genomewide alterations of transcription profiles 1.08
Transcriptome profiling of A2M treated A549 Cell Line Samples 1.07
Landscapes of gene translation in hepatocellular carcinoma tumors revealed by ribosome profiling 1.07
Networks of cultured iPSC-derived neurons reveal the human synaptic activity-regulated adaptive gene program 1.06
RNAseq of quiescent (Q) and stress induced premature senescent (SIPS) fibroblasts treated with plant extract (1201) from Solidago vigaurea subspecies alpestris 1.05
Chromatin mapping and single-cell immune profiling defines the temporal dynamics of ibrutinib drug response in chronic lymphocytic leukemia [scRNA-seq] 1.01
Chromatin mapping and single-cell immune profiling defines the temporal dynamics of ibrutinib drug response in chronic lymphocytic leukemia 1.01
4C-seq of insulin promoter, knockdown of INS promoter activity and Genome-wide maps of chromatin state in EndoC-βH1 Cells 1.0
Viral shRNA Knockdown of INS Promotor Activity in EndoC-βH1 Cells  1.0
An interaction with Ewing's sarcoma breakpoint protein EWS defines the specific oncogenic mechanism of ETS factors rearranged in prostate cancer 0.99
High-throughput single cell transcriptome analysis and CRISPR screen identify key β cell-specific disease genes 0.98
Comparative gene expression profiling of human primary endotheliocytes cultivated on polyurethane-based electrospun 3D matrices and natural decellularized vein 0.95
Integration of ATAC-seq and RNA-seq Identifies Human Alpha Cell and Beta Cell Signature Genes 0.94
Genome-wide analysis of the Integrator complex (HTS) 0.94
Genome-wide analysis of the Integrator complex 0.94
Thyroid State Regulates Gene Expression in Human Whole Blood Cells 0.93
Estrogen-independent molecular actions of mutant estrogen receptor alpha in endometrial cancer [RNA-seq] 0.92
Estrogen-independent molecular actions of mutant estrogen receptor alpha in endometrial cancer 0.92
Assessing placental maturity through histological and transcriptomic analyses in idiopathic spontaneous preterm birth 0.92
Defining the Transcriptional Landscape during Cytomegalovirus Latency with Single-Cell RNA Sequencing 0.9
Trisomy of a ‘Down syndrome critical region’ globally amplifies transcription via HMGN1 overexpression [SLAM-Seq] 0.89
Slit2 modifies VEGF-induced angiogenic responses in rabbit skeletal muscle by inducing capillary sprouting and decreasing vascular permeability via reduced eNOS activity 0.86
RNA-sequencing of Wnt-dependent and Wnt-independent of Glioblastoma stem cell cultures 0.85
Induced DNA demethylation, genome instability and transcription 0.84
Impact of DNA demethylation agents (5-azacytidine or vitamin C) on gene expression in glioblastoma HSR-GBM1 cells 0.84
Genome-wide mapping of DROSHA cleavage sites on primary microRNAs and novel substrates [RNA-seq] 0.79
Genome-wide mapping of DROSHA cleavage sites on primary microRNAs and novel substrates 0.79
Retinoic acid suppresses MYB in adenoid cystic carcinoma [RNA-seq] 0.78
Retinoic acid suppresses MYB in adenoid cystic carcinoma 0.78
Inhibition of TAZ contributes radiation-induced senescence and growth arrest in glioma cells 0.77
Identification of metabolically distinct adipocyte progenitor cells in human adipose tissues 0.76
Genome-wide expression analysis of human hTert immortalized fibroblasts after donwregulation of MCM7 0.74
O-glcnAc reprograms cellular energetics 0.74
KRASG12C inhibition produces a driver-limited state revealing collateral dependencies 0.74
RNA-sequencing analysis of 5' capped RNAs identifies novel differentially expressed genes in sessile serrated colon polyps (SSPs) 0.73
RNA Expression Profile of Calcified Bicuspid, Tricuspid and Normal Human Aortic Valves by RNA Sequencing [BAV] 0.73
Transcriptome of iPSC-derived Cerebral Organoids with Heterozygous Knockout in CHD8 0.68
Small molecule-mediated reprogramming of human hepatocytes into bipotent progenitor cells 0.66
Single-cell RNAseq analysis of the empty and i8TF cell lines after 3 days of BL-CFC culture 0.64
Single cell transcriptomics reveals new insights on the dynamical function of transcription factors during blood stem and progenitor cell formation 0.64
CRISPR Display: A modular method for locus-specific targeting of long noncoding RNAs and synthetic RNA devices in vivo 0.64
CRISPR Display: A modular method for locus-specific targeting of long noncoding RNAs and synthetic RNA devices in vivo [RNA-Seq] 0.64
Exogenous rescue of KLHL9 in SF210 cell line 0.62
Effect of ILF3 depletion in HeLa cells on RNA steady state levels 0.61
GIST cell cycle dysregulation is required for progression to high-risk disease but not for resistance to kinase inhibitors 0.59
Wnt1 silences CC/CXC motif chemokine genes in dendritic cells and induces adaptive immune resistance in lung adenocarcinoma 0.58
Inactivation of CFTR by CRISPR/Cas9 alters transcriptional regulation of inflammatory pathways and other networks 0.55
Transient stabilization, rather than inhibition of MYC amplifies extrinsic apoptosis and therapeutic responses in refractory B-cell lymphoma 0.53
Transcription elongation regulates genome 3D structure 0.47
YTHDF1 Amplifies Wnt/β-Catenin Signaling to Promote Intestinal Stemness 0.46
A novel tumor-associated myeloid cell population inhibits antigen-specific immune responses in cancer patients 0.45
Genome-wide DNA hypomethylation and RNA:DNA hybrid accumulation in Aicardi-Goutières syndrome 0.45
RNA sequencing from FOXM1 knockout HEK293T cells reconstituted with FOXM1 isoforms a, b and c. 0.45
Hsa-miR-371a-5p and hsa-miR-518a-3p regulated genes in choriocarcinoma cells 0.44
Global transcriptome analysis of WT versus HEB-/- hESCs 0.44
Whole transcriptome sequencing of the human thyroid primary cells with knock-down of the NRG1 gene 0.39
Human Treg IFNg/IL-10 subpopulations 0.37
Multi-platform assessment of transcriptional profiling technologies utilizing a precise probe mapping methodology 0.36
Determining mRNA half-lives on a transcriptome-wide scale 0.34
CRISPR/Cas9-mediated ASXL1 mutation in U937 cells perturbs myeloid differentiation 0.34
Single cell transcriptomics analysis of induced pluripotent stem cell-derived cortical neurons reveals frequent dual layer identity 0.33
Widespread regulated alternative splicing of single codons accelerates proteome evolution 0.32
Whole blood stabilization for the microfluidic isolation and molecular characterization of circulating tumor cells 0.32
Alterations of the MEK/ERK, BMP, and Wnt/b-catenin pathways detected in the blood of individuals with lymphatic malformations 0.31
A toxicogenomics approach to screen chlorinated flame retardants tris(2-chloroethyl) phosphate and tris(2-chloroisopropyl) phosphate for potential health effects 0.31
The human cellular nucleic acid binding protien binds G-rich elements close to translation initiation sires and promotes translation. 0.3
The human cellular nucleic acid binding protien binds G-rich elements close to translation initiation sires and promotes translation. [RNA-Seq] 0.3
Cooptation of tandem DNA repeats for the control of epithelial-to-mesenchymal transition [RNA-Seq] 0.25
Cooptation of tandem DNA repeats for the control of epithelial-to-mesenchymal transition. 0.25
Impact of Escherichia coli K12 and O18 on human platelets: effects on platelet activation, spliced platelet RNAs and proteins 0.24
GATA2 promotes hematopoietic development and represses cardiac differentiation of human mesoderm 0.22
Remodeling of Ago2-mRNA interactions upon cellular stress reflects miRNA complementarity and correlates with altered translation rates 0.19
Remodeling of Ago2-mRNA interactions upon cellular stress reflects miRNA complementarity and correlates with altered translation rates (part 4) 0.19
RNA-Seq analysis of human colorectal cancer with liver metastasis 0.17
A novel compound that blocks HIV-1 replication inhibits the splicing regulatory function of SRSF10 0.15
siRNA-mediated knockdown 0.15
Myc activation coordinates gene transcription and protein translation responses 0.13
RNA-seq of HUVEC ± shRNA knockdown of SENCR 0.13
Comparative Transcriptomic Analysis of Hematopoietic System Across Species by Microwell-Seq 0.12
Functional Inflammatory Profiles Distinguish Myelin-Reactive T Cells from Patients with Multiple Sclerosis 0.11
Regulation of stem cell property and drug resistance of cancer cells by targeting transcriptional machinery via inhibition of neddylation 0.11
Multiplexed engineering and analysis of endogenous enhancer activity in single cells: Mosaic-Seq of beta-globin locus (pooled infection) 0.09
Recurrent somatic mutations in POLR2A define a distinct subset of meningiomas [RNA-seq] 0.09
Recurrent somatic mutations in POLR2A define a distinct subset of meningiomas 0.09
Iron response of HepG2 cells 0.09
Targets mediated microRNA arm-imbalance promotes gastric cancer progression [lncRNA] 0.08
Regulation of highly expressed hCINAP on translatome 0.08
Transcriptome-wide off-target RNA editing induced by CRISPR-guided DNA base editors [Modifications - screen] 0.07
Identification of biomarkers for amyotrophic lateral sclerosis by comprehensive analysis of exosomal mRNAs in human cerebrospinal fluid. 0.07
RNA sequencing and pathway analysis identify important pathways involved in hypertrichosis and intellectual disability in patients with Wiedemann-Steiner syndrome 0.05
Differential gene expression by suppression of either SOX2 or TP63 in KYSE70 human esophageal squamous carcinoma cell line. 0.04
transcriptome studies of BRD4 inhibitor BDF-1253 on renal clear carcinoma 786-O cells 0.03
Transcriptome-profiling (RNA-seq) and Ribosome-profiling (Ribo-seq) in proliferation, quiescence, senescence and transformed states. 0.03
Targeting Spt5-Pol II small-molecule inhibitors uncouple distinct activities and reveal additional regulatory roles 0.02
Mitochondrial phosphoenolpyruvate carboxykinase (PCK2) regulates metabolic adaptation and glucose-independent tumor cell growth 0.01
Identification of a unique gene expression signature in mercury and 2,3,7,8-tetrachlorodibenzo-p-dioxin co-exposed cells 0.0
hsa-miR-503, hsa-miR-103, and hsa-miR-494 genome wide target profiles [RNA-Seq and RIP-Seq] 0.0
Genome-wide hsa-miR-503, hsa-miR-103, and hsa-miR-494 target profiles 0.0
Expression analysis of genes modulated after knock-down of lncRNA CHROME. -0.0


Contact Us

For scientific and technical queries contact Butte Lab @UCSF


Cite GENEVA Tool

Manuscript in Preparation